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The human angiotensin II type-2 receptor gene (AT2R) con-
sists of three exons interspaced by two introns.1 Regulatory 
elements are located in the promoter area and in the first 
intron, whereas the third exon contains the complete pro-
tein-coding sequence, which encode the 363-amino acid 
G-protein-coupled receptor.1 AT2R contains several poly-
morphic sites. A common G/A polymorphism occurs at posi-
tion 1675 (rs1403543) relative to the transcription start.2 It is 
also known as –1332G/A relative to the start codon in the first 
intron.2
Fetal tissues express AT2R at high levels.3 In adults, few 
organs express AT2R, but these tissues include the heart, kid-
ney, and vascular endothelium.4 AT2R is an X-chromosome 
linked gene.5 In the European Project on Genes in 
Hypertension (EPOGH), we previously reported association 
between left ventricular structure and the AT2R 1675G/A 
polymorphism, which was modulated by sodium intake.6 
Arterial structure and function shows substantial differences 
between women and men. We hypothesized that variation 
in X-chromosome linked genes might contribute to these 
sex differences. An extensive literature search, using as key 
words “AT2R” or “angiotensin II type 2 receptor” or “angi-
otensin II receptor, type 2,” did not reveal any previous pub-
lication on the association between vascular traits and genetic 
 variants of AT2R in humans. We therefore analyzed the data-
base of the Flemish Study on Environment, Genes and Health 
Outcomes (FLEMENGHO) for possible association between 
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Background
The X-linked angiotensin II type-2 receptor (AT2R) gene 1675G/A 
polymorphism is located in the short intron 1 of the AT2R gene 
within a sequence motif conforming to a splice branch site. AT2r 
is expressed in the human retina, but no previous study examined 
the association between retinal microvascular phenotypes and the 
AT2R 1675G/A polymorphism.
Methods
In 340 subjects randomly selected from a Flemish population (mean 
age, 51.9 years; 51.5% women), we post-processed retinal images 
using IVAN software to generate the retinal arteriole and venule 
equivalents (central retinal arteriolar equivalent (crAe) and central 
retinal venular equivalent (crVe)) and the arteriole-to-venule ratio 
(AVr). dNA fragments including the AT2R 1675G/A polymorphism 
were amplified by Pcr. We applied a mixed model to assess 
phenotype–genotype associations while accounting for relatedness 
and covariables.
results
crAe, crVe, and AVr averaged 151.9 μm, 215.2 μm, and 0.710, 
respectively. crAe was 5.5 μm greater in women than men and 
decreased with age (P < 0.05). In multivariable-adjusted analyses, 
crAe was higher in hemizygous and homozygous carriers of 
the AT2R A allele than in their G allele counterparts in both sexes 
combined (+4.49 μm; P = 0.014) and in men (+4.91 μm; P = 0.032) 
with a similar trend in women (+3.41 μm; P = 0.14). AVr was 
increased in the presence of the AT2R A allele compared with 
AT2R G hemizygotes and homozygotes (+0.024; P = 0.0082). The 
associations of crAe and crVe with other polymorphisms were not 
significant.
conclusions
Pending confirmation in experimental and epidemiological studies, 
our findings suggest that diameter of the retinal arterioles might be 
associated with the AT2R 1675G/A polymorphism.
Keywords: angiotensin II type-2 receptor gene; blood pressure; 
hypertension; polymorphism; microcirculation; retina
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retinal microvascular phenotypes and the AT2R 1675G/A 
polymorphism.
Methods
Study population. Previous publications describe the recruit-
ment of FLEMENGHO participants in detail.7 From August 
1985 until November 1990, a random sample of the households 
living in a geographically defined area of northern Belgium was 
recruited with the goal to enroll an equal number of partici-
pants in each of six subgroups by sex and age (20–39, 40–59, 
and ≥60 years). All household members with a minimum age 
of 20 years were invited to take part, provided that the quota of 
their sex-age group had not yet been fulfilled. From June 1996 
until January 2004 recruitment of families continued using the 
former participants (1985–1990) as index persons and also 
including subjects younger than 20 years. The participation 
rate at enrolment was 65.0%.7
From 10 January 2008 until December 2010, we reinvited 
former participants for a follow-up examination at our field cen-
tre, including imaging of the retinal microvessels. We obtained 
informed written consent from 418 participants (participation 
rate 77.8%). We removed 78 participants from analysis, because 
of low-quality retinal images (n = 54), missing genotypes 
(n = 20), or outlying data points, which were >3 s.d.s. away from 
the mean (n = 4). Thus, our analyses included 340 subjects.
Clinical and biochemical measurements. For at least 3 h before 
the vascular examinations, the participants refrained from 
heavy exercise, smoking, and intake of alcohol, and caffeine-
containing beverages. Trained nurses measured the subjects’ 
anthropometric characteristics and blood pressure. They 
administered a questionnaire to collect information about 
each participant’s recent medical history, smoking and drink-
ing habits, and intake of medications. Each subject’s blood 
pressure was the average of five consecutive readings measured 
after the participants had rested in the sitting position for at 
least 5 min. Hypertension was defined as blood pressure of at 
least 140 mm Hg systolic or 90 mm Hg diastolic, and/or use of 
antihypertensive drugs. Mean arterial pressure was diastolic 
blood pressure plus one third of the difference between systolic 
and diastolic blood pressure. Body mass index was weight in 
kilograms divided by the square of height in meters. On the day 
of the microvascular measurements, with the subjects fasting 
for at least 8 h, venous blood samples were drawn. Using stand-
ardized automated methods, we measured plasma glucose and 
insulin and total and high-density lipoprotein-cholesterol on 
serum. We computed the homeostasis model assessment of 
insulin resistance (HOMAIR) as fasting serum insulin × fast-
ing plasma glucose/22.5. Diabetes mellitus was a self-reported 
diagnosis, use of antidiabetic medication, or a fasting or cas-
ual blood glucose concentration ≥6.99 mmol/l (126 mg/dl) or 
≥11.1 mmol/l (200 mg/dl), respectively.
Microvascular phenotyping. We phenotyped retinal arteri-
oles and venules as described before.8 To dilate the pupil, reti-
nal imaging took place in a dimly lit examination room, after 
the subjects had accommodated to darkness for at least 5 min. 
Trained observers made photographs of each eye by means of a 
Canon Cr-DGi nonmydriatic retinal visualization system com-
bined with a Canon D-50 digital camera (Canon, Kyoto, Japan). 
After converting JPEG to TIFF images, using Phatch (http://
photobatch.stani.be/), two trained observers identified indi-
vidual arterioles and venules for each image, using a validated 
computer-assisted program IVAN (Vasculo-matic ala Nicola, 
version 1.1; Department of Ophthalmology and Visual Science, 
University of Wisconsin-Madison, Madison, WI).9 This software 
combines the individual measurements into summary indexes: 
the central retinal arteriolar equivalent (CRAE) and the central 
retinal venular equivalent (CRVE), based on formulas by Parr 
and Spears10 and by Hubbard et al.11 and Knudtson et al.12 The 
arteriole-to-venule ratio (AVR) was CRAE divided by CRVE.
Genotyping. Genomic DNA was extracted from peripheral 
blood. DNA fragments that contained the polymorphism of 
AT2R (AT2R rs1403543, 1675G/A) were amplified by PCR with 
forward 5′-ATTACGTCCCAGCGTCTGAG-3′ and reverse 
5′-GGCACTAAGCAAGCTGATTTAT-3′ primers. The PCR 
products were digested by the addition of 5 U of Hpy188III restric-
tion enzyme. In the presence of the 1675G allele, the PCR product 
(255 bp) was cut into two fragments of 194 bp and 61 bp in length 
and visualized on ethidium bromide-stained 1.5% agarose gels.
Statistical methods. For database management and statis-
tical analysis, we used SAS software (SAS Institute, Cary, 
NC), version 9.2. We normalized the distributions of insu-
lin and HOMAIR. We compared means and proportions, 
using Student’s t-test and χ2-test, respectively. Our statisti-
cal methods also included single and multiple linear regres-
sions. We searched for possible covariables of the arterial 
phenotypes, using a stepwise regression procedure with 
the P values for independent variables to enter and to stay 
in the model set at 0.15. As covariables, we considered sex, 
age, body mass index, mean arterial pressure, high-density 
lipoprotein-to-total cholesterol, HOMAIR, and design vari-
ables (0, 1), coding for current smoking, alcohol intake and 
use of various classes of antihypertensive drugs (diuretics, 
β-blockers, calcium channel blockers, and inhibitors of the 
renin–angiotensin– aldosterone system). We applied a gener-
alization of the standard linear model, as implemented in the 
PROC MIXED procedure of SAS package, to investigate the 
associations between the retinal phenotypes and explanatory 
variables, while accounting for relatedness among study par-
ticipants and adjusting for covariables.
results
characteristics of the participants
Our study sample included 340 subjects from 157 families 
with a size ranging from 1 to 36 individuals. The participants 
included 175 women (51.5%) and 157 hypertensive patients 
(46.2%). Mean age was 51.9 years (range: 16.7–79.1). Table 1 
lists the characteristics of the participants by sex. Compared 
with men, women had lower blood pressures and plasma 
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glucose, but higher high-density lipoprotein-cholesterol. Of 
340 participants, 64 (18.8%) were current smokers, and 210 
(61.8%) reported regular alcohol intake. In current  smokers 
of either sex, median tobacco use was 12 cigarettes/day (inter-
quartile range: 7–20). In participants reporting alcohol intake, 
median alcohol intake was 5 g/day (interquartile range: 5–10) 
among women and 10 g/day (interquartile range: 6–12) 
among men. Only 2 participants (0.6%) had diabetes mellitus.
retinal microvascular phenotypes
In all participants, CRAE, CRVE, and AVR averaged 151.9 μm, 
215.2 μm, and 0.710, respectively (Table 2). CRAE and AVR 
were 5.5 μm and 0.015 higher in women than men, whereas 
CRVE was similar in both sexes (Table 2). CRAE and CRVE 
decreased with age (P for trend ≤0.0423) in women as well 
as men (Figure 1). In women, the correlation coefficients of 
CRAE and CRVE with age were –0.12 (P = 0.14) and –0.21 
(P = 0.046), whereas in men these correlations were –0.24 
(P = 0.0034) and –0.33 (P = 0.0019), respectively.
In stepwise regression analysis (Table 3), the covariables con-
sidered for entry into the model were sex, age, body mass index, 
mean arterial pressure, high-density lipoprotein-to-total choles-
terol ratio, HOMAIR, smoking, and drinking alcohol. Sex and 
age were forced into the model. In addition to sex and age, mean 
table 1 | characteristics of participants
Characteristic Women Men All
Number 175 165 340
Mean (s.d.) of characteristic
 Age (years) 50.8 ± 14.0 53.1 ± 14.8 51.9 ± 14.4
 body mass index (kg/m2) 26.6 ± 4.9 27.1 ± 4.0 26.9 ± 4.5
 Systolic blood pressure (mm Hg) 127.5 ± 17.5 133.5 ± 15.0*** 130.4 ± 16.6
 diastolic blood pressure (mm Hg) 78.1 ± 9.6 83.0 ± 10.1*** 80.5 ± 10.1
 mean arterial pressure (mm Hg) 94.6 ± 10.6 99.8 ± 10.5*** 97.1 ± 10.9
 Total cholesterol (mmol/l) 5.26 ± 0.89 5.26 ± 1.06 5.26 ± 0.970
 HdL-lipoprotein (mmol/l) 1.58 ± 0.35 1.31 ± 0.28*** 1.45 ± 0.34
 HdL-to-total cholesterol 0.30 ± 0.07 0.26 ± 0.06 0.28 ± 0.07
 Fasting blood glucose (mmol/l) 4.89 ± 0.58 5.20 ± 1.10** 5.04 ± 0.89
Geometric mean (95% CI) of characteristic
 Fasting insulin (mU/l) 5.13 (2.00–14.00) 5.20 (2.00–15.00) 5.16 (2.00–14.50)
 HOmAIr 1.11 (0.42–3.95) 1.18 (0.41–3.81) 1.14 (0.41–3.88)
Number of subjects (%) with characteristic
 current smoking 37 (21.1) 27 (16.5) 64 (18.8)
 drinking alcohol 86 (49.1) 124 (75.1)*** 210 (61.8)
 Hypertension 71 (40.6) 86 (52.1)* 157 (46.2)
Antihypertensive drug treatment
 diuretics 30 (17.1) 21 (12.7) 51 (15.0)
 β-blockers 24 (13.7) 35 (21.2) 59 (17.3)
 Vasodilators 10 (5.7) 12 (7.3) 22 (6.5)
 rAAS inhibitors 14 (8.0) 22 (13.3) 36 (10.6)
Hypertension was a blood pressure of at least 140 mm Hg systolic or 90 mm Hg diastolic, and/or use of antihypertensive drugs. Using of vasodilators included calcium channel blockers 
and α-blockers. Renin–angiotensin–aldosterone system inhibitors included angiotensin II converting enzyme inhibitors and angiotensin II type 1 receptor blockers.
CI, confidence interval; HDL, high-density lipoprotein; HOMAIR, homeostasis model assessment of insulin resistance; RAAS, renin–angiotensin–aldosterone system.
Significance of the difference between men and women: *P < 0.05; **P < 0.01; ***P < 0.001.
table 2 | retinal vascular phenotypes of participants
Characteristic Women Men All
Number 175 165 340
central retinal arteriolar equivalent (μm) 154.6 ± 14.7 149.1 ± 15.2*** 151.9 ± 15.2
central retinal venular equivalent (μm) 216.6 ± 20.0 213.8 ± 20.1 215.2 ± 20.1
Arteriole-to-venule ratio 0.717 ± 0.065 0.702 ± 0.071* 0.710 ± 0.068
Values were mean ± s.d.
Significance of the difference between women and men: *P < 0.05; ***P < 0.001.
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arterial pressure and smoking were correlates of one or more 
retinal phenotypes. For consistency, we adjusted all analyses for 
sex (if appropriate), age, mean arterial pressure, and smoking.
association between microvascular phenotypes and genetic 
polymorphisms
The genotypes and allele frequencies appear in Table 4. The 
genotype frequency of AT2R (1675G/A) in women complied 
with the Hardy–Weinberg equilibrium (P = 0.99). While 
accounting for relatedness and with adjustments applied for 
sex, age, mean arterial pressure, and smoking, CRAE was sig-
nificantly higher in hemizygous and homozygous carriers of 
the AT2R A allele than in their G allele counterparts (Table 4) 
among women and men combined (+4.49 μm; P = 0.014) and 
among men (+4.91 μm; P = 0.032). In women, AA homozy-
gotes had a slightly higher CRAE than G allele carriers, but this 
trend (+3.41 μm; P = 0.14) did not reach significance (Table 5). 
In line with CRAE findings, AVR was significantly higher in 
hemizygous and homozygous carriers of the AT2R A allele 
than in their G allele counterparts (Table 5).
Of our study participants, 15.0% were taking diuretics, 
17.3% β-blockers, 6.5% vasodilators, and 10.6% inhibitors of 
renin–angiotensin–aldosterone system. Sensitivity analyses 
in which we additionally adjusted for antihypertensive drug 
treatment using design variables for four major drug classes 
were confirmatory.
discussion
In the present study, using a candidate gene approach, we 
focused on the retinal vasculature in relation to the AT2R 
table 3 | determinants of retinal vascular phenotypes
Determinant Central retinal arteriolar equivalent Central retinal venular equivalent Arteriole-to-venule ratio
R2 0.142 0.073 0.037
Intercept 1.461 0.449 –0.412
Regression coefficients
 Sex (0, 1) 3.585 ± 1.583* 1.852 ± 2.121 0.007 ± 0.008
 Age (years) –0.190 ± 0.056*** –0.289 ± 0.074*** –0.816 ± 2.713 (×104)
 mean arterial pressure (mm Hg) –0.237 ± 0.078*** — –0.829 ± 0.338 (×103)*
 current smoking (0, 1) 5.763 ± 2.000*** 7.723 ± 2.706** —
The covariables considered for entry into the model were sex, age, BMI, mean arterial pressure, HDL-to-total cholesterol, HOMAIR, current smoking, and drinking alcohol. Sex and age 
were forced into the models.
BMI, body mass index; HDL, high-density lipoprotein; HOMAIR, homeostasis model assessment of insulin resistance.
Significance of the multiple partial correlation: *P < 0.05; **P < 0.01; ***P < 0.001.
table 4 | allele and genotype frequencies
Gene Allele Genotype P
AGTr2 (women) A G AA AG GG
186 (53.1) 164 (46.9) 50 (28.6) 86 (49.1) 39 (22.3) 0.99
AGTr2 (men) A G A G
86 (52.1) 49 (47.9) 86 (52.1) 49 (47.9) —
Values indicate number of alleles or genotypes (%). P values test departure from the Hardy–Weinberg equilibrium. 
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Figure 1 | retinal vascular phenotypes by sex and age. data are mean ± s.e. P values are for linear trend across the age groups.
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1675G/A polymorphism. The retinal vessels as visualized by 
nonmydriatic retinal imaging are believed to reflect the sys-
temic microcirculation and carry important prognostic infor-
mation. To our knowledge no previous study addressed the 
association of this phenotype with genetic variation in the 
X-linked AT2R gene. The key finding of our study was that 
AT2R AA homozygotes and A hemizygotes compared with 
their GG and G counterparts had higher CRAE in both sexes 
combined and in men with a similar trend in women.
Taarnhøj et al.13 and colleagues enrolled 55 monozygotic 
and 50 dizygotic same-sex healthy twin pairs, aged 20–46 
years, in a study of the heritability of the retinal microcircula-
tion. Heritability was 70% (95% CI: 54–80%) for CRAE and 
83% (95% CI: 73–89%) for CRVE.13 As in our current study, 
retinal artery diameter decreased with advancing age and 
higher arterial blood pressure. As reviewed in detail else-
where,14 all components of the renin–angiotensin system are 
expressed within the retina. Angiotensin II, the main effector 
peptide of the renin–angiotensin system causes vasoconstric-
tion of the retinal arterioles,15 capillaries,16 and venules.17 In 
addition, there is evidence that angiotensin II also regulates 
glial18 and neuronal19 function in the central nervous sys-
tem, of which the retina is part. Most aforementioned effects 
of angiotensin II are mediated via AT1R. However, both AT1R 
and AT2R are expressed in the retina of rats20 and humans.21 
Moreover, several genome-wide association studies22–24 high-
lighted loci, which were significantly related to the arterial and 
venular diameters. Thus, evidence from heritability, genome-
wide association studies and expression studies justifies our 
prespecified hypothesis and current analysis.
The AT2R 1675G/A polymorphism is likely to be func-
tional. It is located in the short intron 1 of the AT2R gene 
within a sequence motif similar to the splice branch site 
consensus.2 Warnecke et al.2 and colleagues investigated 12 
explanted human hearts from 2 GG homozygous women and 
10 hemizygous men (7 A and 3 G allele carriers). Irrespective 
of the allele present, the AT2R splice pattern was similar with 
a relative abundance of transcript exon 1/2/3 compared with 
exon 1/3. However, in transfected human (HT1080 (fibrosar-
coma)) and rat (PC12W (pheochromocytoma)) cell lines and 
in rat smooth muscle cells, the luciferase activity driven by the 
G allele construct was significantly higher than that expressed 
from the A allele. Warnecke’s observations2 indicated that 
individuals carrying the G allele may express higher levels of 
AT2R protein, but not mRNA. In contrast, Nishimura et al.25 
and colleagues identified in primary fibroblasts derived from 
men and in uterine tissue from homozygous women differ-
ences in the AT2R splice pattern. A allele carriers expressed 
only splice variant exon 1/2/3 at a high level, whereas G allele 
carriers expressed only splice variant exon 1/3 at a low level. 
Nishimura and colleagues suggested that the G allele might be 
associated with reduced AT2R transcription, although they 
did not present protein expression data in support of that con-
tention. The apparent discrepancies between the aforemen-
tioned studies might be due to the use of different tissues and 
cell models. However, both studies2,25 suggest that the AT2R 
1675G/A polymorphism might lead to differences in AT2R 
expression, which might be important from a pathophysiolog-
ical point of view.
Whether the lower diameter of the retinal arterioles in 
hemizygous or homozygous carriers of the AT2R G allele is due 
to structural or functional alterations remains to be elucidated. 
AT2R regulates cell growth.26 It is expressed at low levels in nor-
mal tissues,26 but upregulated in pathological states.4,27 In the 
presence of hypertension or high-sodium intake, left ventricular 
mass as measured by echocardiography6 or magnetic resonance 
imaging28 was higher in AT2R G allele  carriers. These observa-
tions might favor a structural explanation of our current find-
ings, for instance by hyperplasia or hypertrophy of the vascular 
smooth muscle cells. On the other hand, activation of the AT2R 
receptor might attenuate or antagonize AT1R-mediated physio-
logic effects. In favor of a functional explanation are experiments 
table 5 | association of retinal vascular phenotypes with gene polymorphisms
Genes Mean ± s.e. Difference (95% CI) P
AT2R (women) AA (n = 50) AG+GG (n = 125)
 crAe 159.1 ± 2.0 155.7 ± 1.4 3.41 (–1.12 to 7.95) 0.14
 crVe 217.1 ± 2.9 219.6 ± 2.0 –2.48 (–9.03 to 4.07) 0.45
 AVr 0.738 ± 0.010 0.712 ± 0.007 0.025 (0.004–0.047) 0.021
AT2R (men) A (n = 86) G (n = 79)
 crAe 153.1 ± 2.0 148.2 ± 2.0 4.91 (0.43–9.38) 0.0320
 crVe 217.0 ± 2.7 216.7 ± 2.6 0.292 (–5.762 to 6.346) 0.92
 AVr 0.712 ± 0.009 0.686 ± 0.009 0.027 (0.005–0.048) 0.017
AT2R (all) AA or A (n = 136) GG or G (n = 118)
 crAe 155.6 ± 1.5 151.1 ± 1.5 4.49 (0.92–8.06) 0.0143
 crVe 217.0 ± 2.1 216.3 ± 2.1 0.638 (–4.178 to 5.454) 0.79
 AVr 0.724 ± 0.007 0.700 ± 0.008 0.024 (0.006–0.041) 0.0082
The measurements accounted for family cluster and were adjusted for sex, age, mean arterial pressure, and current smoking.
AT2R, angiotension II type-2 receptor; AVR, arteriole-to-venule ratio; CI, confidence interval; CRAE, central retinal arteriolar equivalent; CRVE, central retinal venular equivalent.
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showing an increased retinal blood flow in response to flicker 
light stimulation, which might be due to an AT2R-mediated 
nitric oxide-dependent mechanism.29–31
The present study must be interpreted within the context 
of its limitations. First, the sample size was small and the par-
ticipants had a wide range of age and blood pressure. Second, 
the retinal photographs were taken independent of the car-
diac cycle and effects of pulsatility on vessel width cannot 
be ruled out.11 Third, we did not adjust for multiple testing. 
Adjustment for multiple comparisons is usually recommended 
to avoid rejecting null hypotheses too readily.32 In the present 
study the correlation between the three phenotypes of interest 
(CRAE, CRVE, and AVR) were ≥0.49, In such case, multiple 
testing is not indicated, because each new test does not provide 
a completely independent opportunity for a type I error.33,34 
Moreover, our main findings were hypothesis driven and 
focused on a single polymorphism in the AT2R gene.
In conclusion, retinal microvascular phenotypes might be 
associated with the AT2R 1675G/A polymorphism. However, 
these observations need confirmation in a larger population 
sample and different cohorts.
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